Insights

Growth Momentum Legend Biotech is a commercial-stage biotechnology company with rising revenue and a track record of profitability improvements, presenting a ready market for scaled partnerships, contract manufacturing, and technology licensing opportunities.

Strategic Leadership Frequent CEO transitions and interim leadership signal ongoing strategic pivots and scale-up efforts, creating openings for executive-level collaborations, advisory roles, and targeted enterprise partnerships aligned with new growth directions.

Global Manufacturing With manufacturing facilities in the United States, China, and Belgium, Legend Biotech seeks expanded capacity, technology transfer, and cross-border supply agreements to support global demand for novel therapies.

Commercial Scale Recent strong quarterly revenue growth and the first signs of profitability indicate readiness for value-added partnerships in commercialization, including product co-marketing, distribution, and market access collaborations.

Digital & Ops Readiness Adoption of cloud and digital tools (Databricks, Azure, Google Cloud, DocuSign, Coupa) signals potential for enterprise SaaS deployments, data integration services, and supplier/vendor optimization programs to improve efficiency and compliance.

Similar companies to Legend Biotech

Legend Biotech Tech Stack

Legend Biotech uses 8 technology products and services including Databricks, Azure DevOps, Shopify, and more. Explore Legend Biotech's tech stack below.

Media & News

Legend Biotech's Email Address Formats

Legend Biotech uses at least 4 email formats:
Legend Biotech Email FormatsExamplePercentage
First.Last@legendbiotech.comJohn.Doe@legendbiotech.com
94%
FirstLast@legendbiotech.comJohnDoe@legendbiotech.com
3%
First.MiddleLast@legendbiotech.comJohn.MichaelDoe@legendbiotech.com
2%
Last.First@legendbiotech.comDoe.John@legendbiotech.com
1%

Frequently Asked Questions

What is Legend Biotech's stock symbol?

Minus sign iconPlus sign icon
Legend Biotech is a publicly traded company; the company's stock symbol is LEGN.

What is Legend Biotech's official website and social media links?

Minus sign iconPlus sign icon
Legend Biotech's official website is legendbiotech.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Legend Biotech generate?

Minus sign iconPlus sign icon
As of October 2026, Legend Biotech's annual revenue is estimated to be $1B - $10B.

What is Legend Biotech's SIC code and NAICS code?

Minus sign iconPlus sign icon
Legend Biotech's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Legend Biotech have currently?

Minus sign iconPlus sign icon
As of October 2026, Legend Biotech has approximately 2.6K employees across 5 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: I. Z., Vice President Clinical Development: T. L. and President, Research And Development: G. F. Explore Legend Biotech's employee directory with LeadIQ.

What industry does Legend Biotech belong to?

Minus sign iconPlus sign icon
Legend Biotech operates in the Biotechnology Research industry.

What technology does Legend Biotech use?

Minus sign iconPlus sign icon
Legend Biotech's tech stack includes Databricks, Azure DevOps, Shopify, Microsoft 365, Azure Active Directory, Google Cloud, DocuSign and Coupa.

What is Legend Biotech's email format?

Minus sign iconPlus sign icon
Legend Biotech's email format typically follows the pattern of First.Last@legendbiotech.com. Find more Legend Biotech email formats with LeadIQ.

How much funding has Legend Biotech raised to date?

Minus sign iconPlus sign icon
As of October 2026, Legend Biotech has raised $750M in funding. The last funding round occurred on May 05, 2023 for $350M.
Legend Biotech logo

Legend Biotech

Biotechnology ResearchNew Jersey, United States1001-5000 Employees

Legend Biotech is a global biotechnology company focused on the development and manufacture of novel cell therapies to address patient needs worldwide. It operates as a commercial-stage enterprise with a manufacturing footprint spanning the United States, China, and Belgium, and is headquartered in Somerset, New Jersey. The company has engaged in clinical development and has presented data for its CAR-T therapies at major oncology meetings, underscoring active participation in the field.

In 2026, Legend Biotech expanded its manufacturing capacity in New Jersey and maintains a collaboration with Novartis under which Legend leads the U.S. Phase 1 program for LB2102, with broader development and commercialization handled outside certain rights. The firm has participated in high-profile industry events, including ASCO and the JP Morgan Healthcare Conference, reflecting ongoing engagement with the clinical and investment communities.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
LEGN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $750M

    Legend Biotech has raised a total of $750M of funding over 3 rounds. Their latest funding round was raised on May 05, 2023 in the amount of $350M as a Post IPO Equity.

  • $1B - $10B

    Legend Biotech's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.